News & Updates

Ritlecitinib, brepocitinib show promise against scalp alopecia areata

22 Apr 2022

Ritlecitinib and brepocitinib lead to improvements in scalp alopecia areata and its associated biomarkers, reveals a recent substudy of a phase 2a trial.

Ritlecitinib, brepocitinib show promise against scalp alopecia areata

22 Apr 2022

Finerenone reduces CV events, renal outcomes in T2D-related CKD

22 Apr 2022 by

A pooled analysis of 13,171 patients from both the FIDELIO-DKD and FIGARO-DKD trials has confirmed the beneficial effects of finerenone, according to results of FIDELITY study, presented at the recently concluded American College of Cardiology Annual Scientific Session (ACC 2022).

Finerenone reduces CV events, renal outcomes in T2D-related CKD

22 Apr 2022

Can we predict sudden cardiac arrests in the general population?

22 Apr 2022 by

The quest for a personalized risk model that can foretell sudden cardiac arrests (SCAs) in the general population remains, as the ESCAPE-NET* research project falls short in their pursuit to identify such a model that can predict SCA risk in this population.

Can we predict sudden cardiac arrests in the general population?

22 Apr 2022

Larger tumours tied to prostate cancer biochemical recurrence

22 Apr 2022

In patients with localized prostate cancer (PCa), higher tumour volume (TV) appears to cut biochemical recurrence-free survival short, a recent study has found.

Larger tumours tied to prostate cancer biochemical recurrence

22 Apr 2022

Increased intake of dietary cholesterol, eggs detrimental to heart

22 Apr 2022

Consuming dietary cholesterol and eggs in high amounts contributes to an increased risk of overall and cardiovascular disease mortality, according to a large study.

Increased intake of dietary cholesterol, eggs detrimental to heart

22 Apr 2022

Mitapivat increases Hb levels in patients with pyruvate kinase deficiency

22 Apr 2022 by

The use of mitapivat increased haemoglobin (Hb) levels in patients with pyruvate kinase deficiency (PKD) who did not receive any regular blood transfusions, according to the ACTIVATE* study.

Mitapivat increases Hb levels in patients with pyruvate kinase deficiency

22 Apr 2022

Does reducing salt intake impact CV outcomes?

21 Apr 2022 by

An intervention aimed at reducing sodium intake in patients with heart failure (HF) does not reduce the risk of emergency department (ED) presentation or hospitalization for cardiovascular (CV) causes or all-cause death, according to results of the SODIUM-HF* trial. However, patients did experience improvements in quality of life (QoL) and New York Heart Association (NYHA) class.

Does reducing salt intake impact CV outcomes?

21 Apr 2022

No link seen between body iron stores and cardiovascular risk

21 Apr 2022

Markers of body iron stores, such as serum ferritin or serum transferrin receptor, are not associated with coronary heart disease events, as reported in a recent study.

No link seen between body iron stores and cardiovascular risk

21 Apr 2022

Novel polypill drug: 2 better than 1 for Parkinson’s disease

21 Apr 2022 by

Taking P2B001, a novel polypill comprising fixed-dose combination of 0.6 mg pramipexole (PPX) and 0.75 mg of rasagiline (RAS), was better than taking either drug component alone for symptomatic control of Parkinson’s disease, according to results of a late-breaking phase III study presented at AAN 2022.

Novel polypill drug: 2 better than 1 for Parkinson’s disease

21 Apr 2022

Is coffee good for the heart?

21 Apr 2022 by

Drinking two to three cups of coffee daily is good for the health, lowering the risk of cardiovascular disease (CVD) and even promoting longevity in individuals with or without heart problems, according to three studies presented at the American College of Cardiology’s (ACC) Annual Scientific Session 2022.

Is coffee good for the heart?

21 Apr 2022

News & Updates

Filter by Specialty:

Specialty:

Ritlecitinib, brepocitinib show promise against scalp alopecia areata

Ritlecitinib, brepocitinib show promise against scalp alopecia areata

Finerenone reduces CV events, renal outcomes in T2D-related CKD

Finerenone reduces CV events, renal outcomes in T2D-related CKD

Can we predict sudden cardiac arrests in the general population?

Can we predict sudden cardiac arrests in the general population?

Larger tumours tied to prostate cancer biochemical recurrence

Larger tumours tied to prostate cancer biochemical recurrence

Increased intake of dietary cholesterol, eggs detrimental to heart

Increased intake of dietary cholesterol, eggs detrimental to heart

Mitapivat increases Hb levels in patients with pyruvate kinase deficiency

Mitapivat increases Hb levels in patients with pyruvate kinase deficiency

Does reducing salt intake impact CV outcomes?

Does reducing salt intake impact CV outcomes?

No link seen between body iron stores and cardiovascular risk

No link seen between body iron stores and cardiovascular risk

Novel polypill drug: 2 better than 1 for Parkinson’s disease

Novel polypill drug: 2 better than 1 for Parkinson’s disease

Is coffee good for the heart?

Is coffee good for the heart?